CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.

Difference between revisions of "Glycosyltransferase Family 38"

From CAZypedia
Jump to navigation Jump to search
Line 33: Line 33:
 
== Substrate specificities ==
 
== Substrate specificities ==
  
Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain <cite>          Cho1994</cite>. These enzymes build the polymer as a capsular polysaccharide on a specialized poly-β-KDO modified lyso-phosphatidyl glycerol anchor in the membrane of Gram negative bacteria <cite>Willis2013</cite>. Bacterial polySia capsules exist in three different flavours: ''Escherichia coli'' K1, ''Neisseria meningitidis'' serotype B, ''Moraxella nonliquefaciens'', and ''Mannheimia haemolytica'' A2 synthesize α-2,8-linked polySia whereas ''N. meningitidis'' serotype C produces a α-2,9-linked polymer and ''E. coli'' K92 produces polymers with alternating α-2,8 and α-2,9 linkages <cite>Jennings1977</cite> <cite>PuentePolledo</cite><cite>Devi1991</cite><cite>Glode1977</cite>.  ''In vitro'' enzyme reactions have shown that the members of GT-38 require two sialic acids for elongation <cite>Willis2008</cite><cite>Peterson2011</cite><cite>Lindhout2013</cite>, presumably as this mimics the ''in vivo'' lipid primer. The molecular mimicry of these bacterial polySia capsules represents an elegant strategy to evade the host’s immune recognition since they are not considered as foreign. In addition, they confer a physical barrier protecting the pathogen from killing by the complement system <cite>Vogel1991</cite>.
+
Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain <cite>          Cho1994</cite>. These enzymes build the polymer as a capsular polysaccharide on a specialized poly-β-KDO modified lyso-phosphatidyl glycerol anchor in the membrane of Gram negative bacteria <cite>Willis2013</cite>. Bacterial polySia capsules exist in three different flavours: ''Escherichia coli'' K1, ''Neisseria meningitidis'' serotype B, ''Moraxella nonliquefaciens'', and ''Mannheimia haemolytica'' A2 synthesize α-2,8-linked polySia whereas ''N. meningitidis'' serotype C produces a α-2,9-linked polymer and ''E. coli'' K92 produces polymers with alternating α-2,8 and α-2,9 linkages <cite>Jennings1977</cite> <cite>PuentePolledo</cite><cite>Devi1991</cite><cite>Glode1977</cite>.  ''In vitro'' enzyme reactions have shown that the members of GT-38 require two sialic acids for elongation <cite>Willis2008</cite><cite>Peterson2011</cite><cite>Lindhout2013</cite>, presumably as this mimics the ''in vivo'' lipid primer. The enzymes have been used in applications to modify therapeutic proteins and prepare synthetic vaccines <cite>Lindhout2011</cite><cite>McCarthy2013</cite>, where un-natural acceptors like protein N-glycans have been used.
  
 
== Kinetics and Mechanism ==
 
== Kinetics and Mechanism ==
Line 66: Line 66:
 
# Lindhout2013 pmid=23922842
 
# Lindhout2013 pmid=23922842
 
# Peterson2011 pmid=21278299
 
# Peterson2011 pmid=21278299
 +
 +
# Lindhout2011 pmid=21502532
 +
# McCarthy2013 pmid=23949787
 +
 
# Willis2013 pmid=23610430
 
# Willis2013 pmid=23610430
 
# Willis2008 pmid=18000029
 
# Willis2008 pmid=18000029

Revision as of 13:23, 27 May 2020


Under construction icon-blue-48px.png

This page is currently under construction. This means that the Responsible Curator has deemed that the page's content is not quite up to CAZypedia's standards for full public consumption. All information should be considered to be under revision and may be subject to major changes.


Glycosyltransferase Family GT38
Clan GT-B
Mechanisn inverting
Active site residues known
CAZy DB link
https://www.cazy.org/GT38.html


Substrate specificities

Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain [1]. These enzymes build the polymer as a capsular polysaccharide on a specialized poly-β-KDO modified lyso-phosphatidyl glycerol anchor in the membrane of Gram negative bacteria [2]. Bacterial polySia capsules exist in three different flavours: Escherichia coli K1, Neisseria meningitidis serotype B, Moraxella nonliquefaciens, and Mannheimia haemolytica A2 synthesize α-2,8-linked polySia whereas N. meningitidis serotype C produces a α-2,9-linked polymer and E. coli K92 produces polymers with alternating α-2,8 and α-2,9 linkages [3] [4][5][6]. In vitro enzyme reactions have shown that the members of GT-38 require two sialic acids for elongation [7][8][9], presumably as this mimics the in vivo lipid primer. The enzymes have been used in applications to modify therapeutic proteins and prepare synthetic vaccines [10][11], where un-natural acceptors like protein N-glycans have been used.

Kinetics and Mechanism

Content is to be added here.

Catalytic Residues

Content is to be added here.

Three-dimensional structures

Content is to be added here.

Family Firsts

First stereochemistry determination
Content is to be added here.
First catalytic nucleophile identification
Content is to be added here.
First general acid/base residue identification
Content is to be added here.
First 3-D structure
Content is to be added here.

References

  1. Cho JW and Troy FA 2nd. (1994). Polysialic acid engineering: synthesis of polysialylated neoglycosphingolipids by using the polysialyltransferase from neuroinvasive Escherichia coli K1. Proc Natl Acad Sci U S A. 1994;91(24):11427-31. DOI:10.1073/pnas.91.24.11427 | PubMed ID:7972078 [Cho1994]
  2. Willis LM, Stupak J, Richards MR, Lowary TL, Li J, and Whitfield C. (2013). Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens. Proc Natl Acad Sci U S A. 2013;110(19):7868-73. DOI:10.1073/pnas.1222317110 | PubMed ID:23610430 [Willis2013]
  3. Willis LM, Stupak J, Richards MR, Lowary TL, Li J, and Whitfield C. (2013). Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens. Proc Natl Acad Sci U S A. 2013;110(19):7868-73. DOI:10.1073/pnas.1222317110 | PubMed ID:23610430 [Willis2013]
  4. Jennings HJ, Bhattacharjee AK, Bundle DR, Kenny CP, Martin A, and Smith IC. (1977). Strucutres of the capsular polysaccharides of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance spectroscopy. J Infect Dis. 1977;136 Suppl:S78-83. DOI:10.1093/infdis/136.supplement.s78 | PubMed ID:408435 [Jennings1977]
  5. Puente-Polledo L, Reglero A, González-Clemente C, Rodríguez-Aparicio LB, and Ferrero MA. (1998). Biochemical conditions for the production of polysialic acid by Pasteurella haemolytica A2. Glycoconj J. 1998;15(9):855-61. DOI:10.1023/a:1006902931032 | PubMed ID:10052589 [PuentePolledo]
  6. Devi SJ, Schneerson R, Egan W, Vann WF, Robbins JB, and Shiloach J. (1991). Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect Immun. 1991;59(2):732-6. DOI:10.1128/iai.59.2.732-736.1991 | PubMed ID:1898915 [Devi1991]
  7. Glode MP, Robbins JB, Liu TY, Gotschlich EC, Orskov I, and Orskov F. (1977). Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis. 1977;135(1):94-104. DOI:10.1093/infdis/135.1.94 | PubMed ID:64575 [Glode1977]
  8. Willis LM, Gilbert M, Karwaski MF, Blanchard MC, and Wakarchuk WW. (2008). Characterization of the alpha-2,8-polysialyltransferase from Neisseria meningitidis with synthetic acceptors, and the development of a self-priming polysialyltransferase fusion enzyme. Glycobiology. 2008;18(2):177-86. DOI:10.1093/glycob/cwm126 | PubMed ID:18000029 [Willis2008]
  9. Peterson DC, Arakere G, Vionnet J, McCarthy PC, and Vann WF. (2011). Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase. J Bacteriol. 2011;193(7):1576-82. DOI:10.1128/JB.00924-10 | PubMed ID:21278299 [Peterson2011]
  10. Lindhout T, Bainbridge CR, Costain WJ, Gilbert M, and Wakarchuk WW. (2013). Biochemical characterization of a polysialyltransferase from Mannheimia haemolytica A2 and comparison to other bacterial polysialyltransferases. PLoS One. 2013;8(7):e69888. DOI:10.1371/journal.pone.0069888 | PubMed ID:23922842 [Lindhout2013]
  11. Lindhout T, Iqbal U, Willis LM, Reid AN, Li J, Liu X, Moreno M, and Wakarchuk WW. (2011). Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes. Proc Natl Acad Sci U S A. 2011;108(18):7397-402. DOI:10.1073/pnas.1019266108 | PubMed ID:21502532 [Lindhout2011]
  12. McCarthy PC, Saksena R, Peterson DC, Lee CH, An Y, Cipollo JF, and Vann WF. (2013). Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates. Glycoconj J. 2013;30(9):857-70. DOI:10.1007/s10719-013-9490-x | PubMed ID:23949787 [McCarthy2013]
  13. pmid= 8884739

    [Vogel1991]
  14. Lizak C, Worrall LJ, Baumann L, Pfleiderer MM, Volkers G, Sun T, Sim L, Wakarchuk W, Withers SG, and Strynadka NCJ. (2017). X-ray crystallographic structure of a bacterial polysialyltransferase provides insight into the biosynthesis of capsular polysialic acid. Sci Rep. 2017;7(1):5842. DOI:10.1038/s41598-017-05627-z | PubMed ID:28724897 [Lizak2017]

All Medline abstracts: PubMed